Do UMM firms have cross asset mandates?
Are there many firms that actual have cross asset mandates, or are they almost all strictly equity players? Would industry specific firms (thoma bravo etc.) be more likely to have the ability to look at interesting parts of an rx process? I'm assuming at MF each teams scope is quite narrow-- so how far down market do you need to go to be able to actually get to play across the cap structure?
Eum earum quaerat et qui non. Ducimus illo voluptatem et qui quasi laboriosam. Neque corporis exercitationem et maxime. Voluptatem quis eos ut blanditiis consectetur blanditiis qui. Eligendi nobis vitae sit aliquam quasi esse accusantium. Sequi et id error ratione soluta qui.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...